Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 5.72% | 0.00% | 21.10% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -76.84% | 0.00% | 150.50% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 233.83% | 0.00% | -25.22% | 0.00% |
| Change in Net Operating Assets | 0.00% | -1,253.91% | 0.00% | 84.72% | 0.00% |
| Cash from Operations | 0.00% | 31.50% | 0.00% | 29.05% | 0.00% |
| Capital Expenditure | -- | 100.00% | 0.00% | -107.59% | 0.00% |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -- | -- | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 0.00% |
| Other Investing Activities | 0.00% | -33.33% | 0.00% | -400.00% | 0.00% |
| Cash from Investing | 0.00% | -29.03% | 0.00% | -303.43% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | 0.00% | 27.16% | 0.00% | -145.82% | 0.00% |
| Issuance of Common Stock | 0.00% | 33.35% | 0.00% | -73.32% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 52.78% | 0.00% | -81.21% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -94.51% | 0.00% | -70.83% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 76.37% | 0.00% | -182.25% | 0.00% |